<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Cherny, Nathan I.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The International Collaborative Project to Evaluate the Availability and Accessibility of Opioids for the Management of Cancer Pain in Africa, Asia, the Middle East, and Latin America</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">27-27</style></pages><abstract><style  face="normal" font="default" size="100%">Adequate relief of the pain associated with cancer is now recognized as a patient right, and opioid analgesics are essential for effective relief of this pain [Cherny NI et al. Ann Oncol 2010]. However, an opioid regulatory paradox exists with 2 conflicting needs: these drugs should be available to the patients who need them, but they should be prevented from becoming a source of abuse. Restrictions on the availability and accessibility of opioids in Africa, Asia, Latin America and the Caribbean, and the Middle East pose a major public health problem. This article reports on new data on the state of management of cancer pain in these countries.</style></abstract><number><style face="normal" font="default" size="100%">15</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>